The apprehensions about Russian vaccine before completing the corona vaccine tests seem to be unfounded. Russia’s Sputnik V vaccine has been successful in generating immunity with sufficient antibodies. This has increased the possibility of vaccination in the world this year. The prestigious medical journal Lancet reported on Friday that the Covid vaccine was found to be poor in the study.
In fact, Russia, after completing the first two-stage human trials, announced to meet the vaccine standards and begin vaccination on 11 August. However, the tests of Russia’s first two phases were not monitored by the WHO or any other reputable institution. In such a situation, scientific institutions across the world had expressed doubts about the vaccine. Russia’s Gamalaya Research Institute is also testing Phase III vaccines on 40,000 volunteers. However, at-risk groups are already being vaccinated.
The Lancet report is the first seal on Russian vaccines globally. Lancet found that 76 volunteers who had vaccinated in the first two stages produced enough antibodies and neutralized the Covid-19 virus. London School of Hygiene and Tropical Medicine scientist Brendan Rein said that this is good news for the whole world, but we will have to wait for the third phase of testing. Vaccination showed minor side effects such as fever, headache, joint pain.
Russia will begin mass immunization of Sputnik V from October. One billion doses have been signed with 20 countries (Turkey, Philippines etc.) and Russia is in touch with the Department of Biotechnology of India regarding production.